Related stories
Suominen Q3 Revenue EUR 101.1 Million
M impact | EQUITY | Nov 05, 2026, 07:02 AM UTC
T-Therapeutics Announces Oversubscribed $133 Million Series B Financing
T-Therapeutics says the financing will support clinical proof-of-concept for its TCR bispecific therapies in cancer and autoimmune disease.
L impact | EQUITY | Nov 05, 2026, 07:01 AM UTC
Eesti Energia Reports Unaudited Q3 2026 Results
Eesti Energia Group released unaudited results for Q3 2026.
M impact | EQUITY | Nov 05, 2026, 07:01 AM UTC
Harbour Energy to Buy Back $150M of Shares
M impact | EQUITY | Nov 05, 2026, 07:01 AM UTC
Amaroq sets date for Q3 2026 results and webcast
Amaroq issued a notice about its Q3 2026 results and webcast details.
M impact | EQUITY | Nov 05, 2026, 07:01 AM UTC
Şekerbank shares rise 3.6% in early trading
L impact | EQUITY | Nov 05, 2026, 07:01 AM UTC